West Nile Virus Disease Author: Amy V. Bode, MD, MSPH; James J. Sejvar, MD; Anthony A. Marfin, MD, MPH
Editorial changes - 2008-08-28
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Diagnosis
  • Consider the diagnosis of WNV infection in patients with potential exposure and a compatible clinical presentation.
  • Consider the diagnosis in a person who has been potentially exposed to mosquitoes and who presents with fever, headache, and myalgia, with or without gastrointestinal symptoms, and especially if neck stiffness and/or a change in mental status and/or weakness is present.
  • Collect historical information about conditions that may predispose the patient to a worse prognosis.
  • Use physical exam findings to confirm meningitis, encephalitis, or acute flaccid paralysis and to prognosticate outcome.
  • Confirm the diagnosis with a WNV-specific test, with acute and convalescent serology, by isolating the virus, or with amplification of WNV genomic sequences.
  • Support the diagnosis of WNV encephalitis or other neuroinvasive syndromes with imaging studies.
  • Support the diagnosis of WNV meningitis, encephalitis, or other neuroinvasive syndromes, or identify other associated clinical conditions, with appropriate blood studies.
  • Support the diagnosis of WNV meningitis, encephalitis, or other neuroinvasive syndromes with CSF studies.
  • Support the diagnosis of WNV encephalitis or other neuroinvasive syndromes with additional neurologic studies.
  • Consider the broad differential diagnosis of WNV meningitis, encephalitis, and other neuroinvasive syndromes.
History and Physical Examination Elements for WNV Meningitis, Encephalitis, or Other Neuroinvasive Syndromes (table)
Laboratory and Other Studies for West Nile Viral Illnesses (table)
Differential Diagnosis of WNV Encephalitis, Meningitis, and Other Neuroinvasive Syndromes (table)


Consider the diagnosis of WNV infection in patients with potential exposure and a compatible clinical presentation. C

  • Ask about:
    • Known WNV activity, in humans or animals, in the area where the patient resides
    • Travel to areas where activity or epidemics have been recognized
    • Potential mosquito exposure for the patient
    • Mosquito bites
    • Mosquitoes seen inside home, work, or recreation environments
    • Barrier methods (e.g., screens, long-sleeved shirts) and protective measures (e.g., DEET)
    • Standing water around home or work
    • Blood transfusions in the month prior to presentation
    • Organ transplantation in the month prior to presentation
  • See table History and Physical Examination Elements for WNV Meningitis, Encephalitis, or Other Neuroinvasive Syndromes.
Background | Back to top


Consider the diagnosis in a person who has been potentially exposed to mosquitoes and who presents with fever, headache, and myalgia, with or without gastrointestinal symptoms, and especially if neck stiffness and/or a change in mental status and/or weakness is present. C

Background | Back to top


Collect historical information about conditions that may predispose the patient to a worse prognosis. C

Background | Back to top


Use physical exam findings to confirm meningitis, encephalitis, or acute flaccid paralysis and to prognosticate outcome. C

Background | Back to top


Confirm the diagnosis with a WNV-specific test, with acute and convalescent serology, by isolating the virus, or with amplification of WNV genomic sequences. C

  • Demonstrate IgM by IgM antibody-capture ELISA, and/or
  • Demonstrate four-fold increase in neutralizing antibody titers when comparing acute- and convalescent-phase serum samples (collected 7 to 14 days apart), and/or
  • Amplify WNV nucleic acid sequence from tissue, blood, CSF, or other body fluid, and/or
  • Isolate WNV by cell culture of tissue, blood, CSF, or other body fluid.
  • Encourage autopsy in fatal cases to isolate virus and better characterize pathologic changes, especially in brain and spinal tissue.
  • See table Laboratory and Other Studies for West Nile Viral Illnesses.
Background | Back to top


Support the diagnosis of WNV encephalitis or other neuroinvasive syndromes with imaging studies. C

  • Perform MRI of involved central nervous system components (e.g., brain and/or spinal cord) to exclude a diagnosis of HSV encephalitis and other infectious causes of encephalitis that have highly specific patterns on MRI.
  • See table Laboratory and Other Studies for West Nile Viral Illnesses.
Background | Back to top


Support the diagnosis of WNV meningitis, encephalitis, or other neuroinvasive syndromes, or identify other associated clinical conditions, with appropriate blood studies. C

Background | Back to top


Support the diagnosis of WNV meningitis, encephalitis, or other neuroinvasive syndromes with CSF studies. C

Background | Back to top


Support the diagnosis of WNV encephalitis or other neuroinvasive syndromes with additional neurologic studies. C

Background | Back to top


Consider the broad differential diagnosis of WNV meningitis, encephalitis, and other neuroinvasive syndromes. C

  • When febrile illness progresses over several days with neurologic changes, especially when the findings are compatible with meningitis and/or encephalitis, consider the patient's age, comorbid conditions, and exposure history when considering the differential diagnosis, which includes:
    • Other North American flaviviruses, alphaviruses, and bunyaviruses (St. Louis encephalitis, Powassan fever, Western equine encephalitis, Eastern equine encephalitis, and La Crosse virus)
    • Other infectious encephalitides
    • Other viruses (e.g., HIV, coxsackievirus, echovirus, enterovirus)
    • Bacterial infections (e.g., Lyme disease, Leptospira)
    • Tick paralysis
    • Stroke
    • Brain abscess or paraspinal epidural abscess
    • Brain tumor
  • See table Differential Diagnosis of WNV Encephalitis, Meningitis, and Other Neuroinvasive Syndromes.
Background | Back to top

FAQs
Amy V. Bode, MD, MSPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Anthony A. Marfin, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Carrie Nielsen, PhD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. James J. Sejvar, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.